Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valle Palomo

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Opinion on Therapeutic Patents|November 10, 2016
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)Valle Palomo, Ana Martinez
Nanomedicine : Nanotechnology, Biology, and Medicine|September 15, 2020
CdSe quantum dots evaluation in primary cellular models or tissues derived from patientsCarlota Tosat-Bitrián, Valle Palomo
Advanced Drug Delivery Reviews|March 22, 2025
Nanoparticles targeting the central circadian clock: Potential applications for neurological disordersMarion Le Meur, Jaime Pignatelli, Paolo Blasi, et al.
British Journal of Pharmacology|August 2, 2020
Protein kinase inhibitors for amyotrophic lateral sclerosis therapyValle Palomo, Vanesa Nozal, Elisa Rojas-Prats, et al.
Expert Opinion on Investigational Drugs|March 10, 2017
Drugs in clinical development for the treatment of amyotrophic lateral sclerosisAna Martinez, Maria Del Valle Palomo Ruiz, Daniel I Perez, et al.
Neuropharmacology|July 4, 2012
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J miceTatiana V Lipina, Valle Palomo, Carmen Gil, et al.
Biomedicines|February 25, 2022
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease PatientsEva P Cuevas, Alberto Rodríguez-Fernández, Valle Palomo, et al.
Journal of the American Chemical Society|December 2, 2015
Controlling the Architecture, Coordination, and Reactivity of Nanoparticle Coating Utilizing an Amino Acid Central ScaffoldNaiqian Zhan, Goutam Palui, Anshika Kapur, et al.
ACS Chemical Neuroscience|February 21, 2019
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral SclerosisValle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, et al.
Bioconjugate Chemistry|August 1, 2018
Efficient Assembly of Quantum Dots with Homogenous Glycans Derived from Natural N-Linked GlycoproteinsValle Palomo, Philip A Cistrone, Naiqian Zhan, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Opinion on Therapeutic Patents|November 10, 2016
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)Valle Palomo, Ana Martinez
Nanomedicine : Nanotechnology, Biology, and Medicine|September 15, 2020
CdSe quantum dots evaluation in primary cellular models or tissues derived from patientsCarlota Tosat-Bitrián, Valle Palomo
Advanced Drug Delivery Reviews|March 22, 2025
Nanoparticles targeting the central circadian clock: Potential applications for neurological disordersMarion Le Meur, Jaime Pignatelli, Paolo Blasi, et al.
British Journal of Pharmacology|August 2, 2020
Protein kinase inhibitors for amyotrophic lateral sclerosis therapyValle Palomo, Vanesa Nozal, Elisa Rojas-Prats, et al.
Expert Opinion on Investigational Drugs|March 10, 2017
Drugs in clinical development for the treatment of amyotrophic lateral sclerosisAna Martinez, Maria Del Valle Palomo Ruiz, Daniel I Perez, et al.
Neuropharmacology|July 4, 2012
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J miceTatiana V Lipina, Valle Palomo, Carmen Gil, et al.
Biomedicines|February 25, 2022
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease PatientsEva P Cuevas, Alberto Rodríguez-Fernández, Valle Palomo, et al.
Journal of the American Chemical Society|December 2, 2015
Controlling the Architecture, Coordination, and Reactivity of Nanoparticle Coating Utilizing an Amino Acid Central ScaffoldNaiqian Zhan, Goutam Palui, Anshika Kapur, et al.
ACS Chemical Neuroscience|February 21, 2019
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral SclerosisValle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, et al.
Bioconjugate Chemistry|August 1, 2018
Efficient Assembly of Quantum Dots with Homogenous Glycans Derived from Natural N-Linked GlycoproteinsValle Palomo, Philip A Cistrone, Naiqian Zhan, et al.
Pageof 6